AIDS treatment
Scope
Date
~
-
Bio & Pharma
HLB signs with Japan's OSCL for exclusive supply of C-Trelin ingredient
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has entered into a business agreement with Japan's Osaka Syn...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Ildong Pharma to export high blood pressure treatment to China
South Korea's Ildong Pharmaceutical Co. on Tuesday said it will export benidipine hydrochloride, a raw material used in the treatment of high blood ...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma gets OK for phase 3 clinical trials of URC102 in Taiwan
South Korea's JW Pharmaceutical has won approval from Taiwan's Food and Drug Administration (TFDA) to conduct phase 3 clinical trials for its gout t...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong launches GERD treatment Fexuclu in Philippines
South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...
Aug 01, 2023 (Gmt+09:00)
-
Electronics
LG’s front-load washer selected as best by Consumer Reports
LG Electronics Inc.'s front-load washers have seized the top four spots in the US consumer review conducted by Consumer Reports, earning the title o...
Aug 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s aid service Boram Group enters companion animal market
South Korea’s Boram Group, whose main affiliate is an aid company, has entered the companion animal market. Affiliates Boram Sangjo and ...
Jul 28, 2023 (Gmt+09:00)
-
Construction
GS E&C faces heavy loss in Q2 due to apartment reconstruction plan
GS Engineering & Construction Co., South Korea’s major construction firm, posted a quarterly operating loss in the April-June period for t...
Jul 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Raphas microneedle passes US FDA's cGMP inspection
South Korea's microneedle maker Raphas Co. announced on Wednesday that it has passed the Current Good Manufacturing Practice (cGMP) inspection by ...
Jul 26, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
LG Labs opens door to unconventional idea seekers
South Korea’s home appliance giant LG Electronics Inc. has launched LG Labs, a playground for those wanting to test unconventional ideas that ...
Jul 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong's Nabota exceeds 600,000 customers in US
South Korea's Daewoong Pharmaceutical said on Thursday that its local loyalty program for Nabota (American name: Jeuveau) in the US, a botulinum tox...
Jul 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N releases new drug for GERD in Indonesia
South Korean bio-health company HK inno.N Corporation's new drug for gastroesophageal reflux disease (GERD) K-CAB has been officially launched in In...
Jul 10, 2023 (Gmt+09:00)
-
Batteries
Deal reached on LG-Stellantis battery plant subsidy; construction resumes
All construction work at a battery joint venture in Canada between South Korea’s LG Energy Solution Ltd. and multinational automaker Stellanti...
Jul 06, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung Electronics to aid foundry clients with state-of-the-art tech
Samsung Electronics Co., the world’s largest memory chipmaker, will provide its foundry clients with state-of-the-art technology to support th...
Jul 05, 2023 (Gmt+09:00)
-
E-commerce
Coupang taps former Trump aide for political relations
South Korean e-commerce giant Coupang Inc. hired a top aide of former US President Donald Trump to expand its political network in Washington and se...
Jul 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals, AZ mark first commercial production of diabetes drugs
South Korea's SK Chemicals has joined forces with global pharmaceutical firm AstraZeneca to initiate commercial production of a chemical drug for di...
Jun 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm’s Cenobamate gets nod in Canada, to boost US sales
South Korea’s SK Biopharmaceuticals Co. has obtained the sales approval for its antiepileptic treatment Cenobamate in Canada, paving the way f...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets approval to sell biosimilar in Europe
South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
HanAll, Daewoong to develop Parkinson's treatment with US partner
South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...
May 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Artificial intelligence
Neurophet strives to be first mover in fight against Alzheimer’s
Neurophet Inc., a South Korean startup developing artificial intelligence-powered medical solutions for brain diseases, is striving to make a breakt...
May 24, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea to send $130 mn in aid for Ukraine’s reconstruction
South Korea will aid the reconstruction of Ukraine, which is at war with Russia, through loans worth $130 million from the Economic Development Coop...
May 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for Phase 3 clinical trials in Europe for biosimilar
South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Kainos Medicine exports AIDS treatment technology to China
South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...
Apr 21, 2023 (Gmt+09:00)
-
Korean startups
Asleep dreams big to help sleepless people worldwide find right treatment
Armed with artificial intelligence and big data technologies, Asleep hopes to find the best treatment for sleep-deprived people around the world wit...
Apr 21, 2023 (Gmt+09:00)
-
Korean startups
Korean gov’t pledges additional $7.9 bn for startups amid fund squeeze
The South Korean government will spend an additional 10.5 trillion won ($7.9 billion) to shore up the country’s startups and venture capitalis...
Apr 20, 2023 (Gmt+09:00)
-
Bio & Pharma
AbClon shows promising results in clinical tests of leukemia treatment
South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...
Apr 19, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s KOTRA to aid domestic pharmaceutical firms in Japan entry
The government-run (South) Korea Trade-Investment Promotion Agency (KOTRA) announced on Tuesday that it will hold an export consultation meeting for...
Apr 18, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB starts Phase 3 clinical trials for ophthalmic disease treatment in US
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...
Apr 13, 2023 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer